Cosmo NV (XSWX:CMHC) Accumulated Depreciation: CHF0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:CMHC Cosmo NV XSWX:CMHC
81 GF Score
Price CHF57.10
GF Value CHF40.77
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cosmo NV Accumulated Depreciation?

Cosmo NV XSWX:CMHC -2.89% 81 Accumulated Depreciation is CHF0.00 Mil as of Jun. 2026. GuruFocus rates XSWX:CMHC with a GF Score™ of 81/100 and a GF Value™ of CHF40.77 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cosmo NV's quarterly accumulated depreciation increased from Jun. 2025 (CHF0.00 Mil) to Dec. 2025 (CHF-55.16 Mil) but then stayed the same from Dec. 2025 (CHF-55.16 Mil) to Jun. 2026 (CHF0.00 Mil).

Cosmo NV's annual accumulated depreciation increased from Dec. 2023 (CHF-47.85 Mil) to Dec. 2024 (CHF-50.84 Mil) and increased from Dec. 2024 (CHF-50.84 Mil) to Dec. 2025 (CHF-55.16 Mil).

Cosmo NV Accumulated Depreciation Related Terms

Cosmo NV Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Cosmo NV's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo NV Accumulated Depreciation Chart

Cosmo NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.03 -45.25 -47.85 -50.84 -55.16

Cosmo NV Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -50.84 0.00 -55.16 0.00
XSWX:CMHC
81GF Score
Cosmo NV XSWX:CMHC
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo NV Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of CHF0.00 Mil mean?
Cosmo NV (XSWX:CMHC) has a Accumulated Depreciation of CHF0.00 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Cosmo NV and its competitors.
Is Cosmo NV's Accumulated Depreciation too high?
Cosmo NV's current Accumulated Depreciation is CHF0.00 Mil. Overall, Cosmo NV has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cosmo NV's Accumulated Depreciation compare to LLY and JNJ?
Cosmo NV's Accumulated Depreciation of CHF0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Cosmo NV and its competitors. Cosmo NV's current Accumulated Depreciation is CHF0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo NV stock overvalued right now?
Based on GuruFocus' analysis, Cosmo NV (XSWX:CMHC) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF40.77, compared to a current price of CHF57.10 — trading 40.1% above its estimated fair value. The current Accumulated Depreciation is CHF0.00 Mil. Cosmo NV's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Cosmo NV (XSWX:CMHC), the current Accumulated Depreciation is CHF0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo NV (XSWX:CMHC) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued. The current stock price of CHF57.10 is trading 40.1% above its estimated GF Value™ of CHF40.77. GuruFocus considers Cosmo NV to be Significantly Overvalued.

Key valuation signals for XSWX:CMHC:

  • Accumulated Depreciation: CHF0.00 Mil
  • GF Value™: CHF40.77 vs. price of CHF57.10 (40.1% above fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:CMHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo NV Business Description

Address 91/94 North Wall Quay, 7th Floor, One North Dock, Dublin, IRL, D01 H7V7
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
81GF Score

Get the complete analysis for XSWX:CMHC

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF57.10
Price
CHF40.77
GF Value